Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Trading Down 2.9 %

ENZ opened at $0.64 on Friday. The firm has a fifty day moving average price of $0.82 and a 200 day moving average price of $1.02. Enzo Biochem has a 1 year low of $0.62 and a 1 year high of $1.40.

Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings data on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Investors Weigh In On Enzo Biochem

A number of large investors have recently modified their holdings of the business. Renaissance Technologies LLC grew its holdings in shares of Enzo Biochem by 2.6% in the second quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after purchasing an additional 64,417 shares during the period. XTX Topco Ltd grew its holdings in shares of Enzo Biochem by 94.5% in the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 13,735 shares during the period. BBR Partners LLC purchased a new stake in shares of Enzo Biochem in the third quarter valued at about $112,000. Finally, Geode Capital Management LLC grew its holdings in shares of Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares during the period. Hedge funds and other institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.